Page 4031
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOVATION (IJRSI)
ISSN No. 2321-2705 | DOI: 10.51244/IJRSI |Volume XII Issue IX September 2025
Study Regarding the Bacteriological Profile and Antimicrobial
Susceptibility Pattern of Isolates Obtained from Urinary Tract
Infections: Analysis of Antibiogram from Medicine Department from
Secondary Care Hospital North India
Sharma Devi Komal
1
, Kumari Manisha
2
Department of Microbiology, Zonal hospital Dharamshala, India
DOI: https://dx.doi.org/10.51244/IJRSI.2025.120800361
Received: 04 Sep 2024; Accepted: 11 Sep 2025; Published: 15 October 2025
ABSTRACT
Urinary tract infections (UTIs) remain among the most common bacterial infections worldwide, with
Escherichia coli as the predominant uropathogen. This retrospective study analyzed culture and susceptibility
data from 455 samples processed in the Medicine Department of Zonal Hospital Dharamshala between
JanuaryDecember 2024. Urine was the most frequent specimen (58% OPD, 41% IPD, 1% ICU). E. coli
accounted for the majority of isolates (n=94). High susceptibility was observed to meropenem (91%),
piperacillintazobactam (89%), gentamicin (86%), fosfomycin (84%), and imipenem (84%), supporting their
role in targeted or reserve therapy. Nitrofurantoin (78%) and cefepime (73%) remained moderately effective,
whereas ciprofloxacin (30%), ampicillin (21%), and amoxiclav (53%) showed poor efficacy, limiting their
empirical use. These findings highlight the value of department-specific antibiograms for guiding rational
empirical therapy, preserving carbapenem efficacy, and supporting antimicrobial stewardship initiatives to
mitigate resistance in this secondary-care hospital setting.
Keywords: UTI, E.coli, CLSI , Antibiogram
INTRODUCTION:
Urinary tract infections (UTIs) represent one of the most common bacterial infections encountered in clinical
medicine, particularly in internal medicine and primary care practice. They affect individuals across all age
groups but are particularly frequent among women, older adults, and patients with comorbidities such as
diabetes and renal disease (1). Escherichia coli remains the predominant uropathogen worldwide, responsible
for up to 8090% of community-acquired cases and a significant proportion of hospital-acquired infections
(2)
.
Klebsiella spp., Enterobacter spp., and Enterococcus spp. are recognized as significant secondary uro-
pathogens, particularly in hospitalized patients and those with catheters or underlying comorbidities. Studies
from North India report Klebsiella contributing to 1020% of UTIs, Enterobacter to 37%, and Enterococcus
(often E. faecalis) to 510%, with higher prevalence in nosocomial and complicated infections.
(3)
However, the
antimicrobial susceptibility profile of uro-pathogens is highly dynamic and varies considerably across regions,
institutions, and even within departments of the same hospital. This variability underscores the importance of
local surveillance through hospital- and department-level antibiograms. Globally, increasing resistance to
frontline antibiotics such as fluoroquinolones and aminopenicillins has limited their empirical utility in UTI
management
(4)
. The problem is particularly pressing in India, where irrational use of antibiotics, over-the-
counter availability, and lack of stewardship practices have accelerated antimicrobial resistance (AMR)
(5)
.Department-specific antibiogram data, which reflect the patient demographics and antibiotic exposure patterns
of that unit, are therefore crucial in guiding rational empirical therapy. Such data not only inform clinicians
about the most effective first-line and reserve antibiotics but also help prevent the misuse of broad-spectrum
drugs, thereby curbing further resistance. This study analyses the annual antibiogram from the Medicine
Department of a secondary-care hospital in north India, focusing on pathogen distribution and susceptibility
Page 4032
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOVATION (IJRSI)
ISSN No. 2321-2705 | DOI: 10.51244/IJRSI |Volume XII Issue IX September 2025
trends. By providing evidence-based insights into evolving resistance patterns, the findings aim to strengthen
antimicrobial stewardship, optimize empirical therapy for UTIs, and contribute to regional AMR surveillance
efforts.
Materials and Methods: This study was designed as a retrospective analysis of culture and sensitivity reports
generated in the microbiology laboratory of Zonal Hospital Dharamshala, focusing exclusively on the
Medicine Department. The study period spanned January to December 2024. Out of the 982 total clinical
samples processed in the hospital during this time, the Medicine Department contributed 455 samples (46%),
with urine specimens comprising the majority. Patient demographic analysis revealed that most samples were
submitted from the outpatient department (OPD, 58%), followed by the inpatient wards (IPD, 41%), while a
small proportion originated from the intensive care unit (ICU, 1%). All participants were advised to collect the
midstream urine sample in wide mouth sterile containers after urogenital cleaning with soap and water with
sterile gauze. Samples were processed within 1 hour of collection in microbiology laboratory.
(6)
Screening
tests like wet film preparation and direct gram staining were performed. In Wet film preparation- presence of
one pus cell /7 hpf was considered significant pyuria.
(7)
Direct Gram staining- detection of one or more
morphologically similar bacteria per oil immersion field was treated as significant.
(7)
Urine samples were
inoculated on blood agar and mac-Conkey agar using a standard loop method (semi-quantitative method).
(8)
The plates were read after 24 hours of aerobic incubation at 37 C. They were further incubated for another
24 hours before a negative report is issued. A single organism obtained in counts of>100000 CFU/ml will be
considered as significant bacteriuria. Further identification of pathogen was done by standard biochemical
techniques.
(9)
Kirby Bauer disk diffusion technique was used for antibiotic susceptibility testing of gram
negative or gram-positive pathogens. Interpretation of results were done according to CLSI guidelines. ATCC
control strains were used.
(10)
The antibiotic panel tested included carbapenems, beta-lactam/beta-lactamase
inhibitor combinations, aminoglycosides, Fosfomycin, nitrofurantoin, cephalosporins, fluoroquinolones,
tetracyclines, and aminopenicillins, reflecting the commonly prescribed agents for urinary tract infections and
systemic bacterial infections in routine clinical practice.
RESULTS:
A total of 455 clinical samples were received from the Medicine Department during the study period. The
majority were obtained from the outpatient department (58%), followed by inpatient wards (41%), with only a
small proportion originating from the intensive care unit (1%). Urine was the predominant specimen type,
consistent with the departments clinical burden of urinary tract infections. Microbiological analysis revealed
that Escherichia coli (79.7%) was the leading pathogen, followed by Klebsiella pneumoniae (16.1%) and
Pseudomonas aeruginosa (1.7%) as depicted in Figure:1 . As the Escherichia coli was the predominant
pathogen susceptibility pattern is demonstrated for it as high sensitivity to carbapenems and certain first-line
agents, with Meropenem (91%), PiperacillinTazobactam (89%), Gentamicin (86%), Fosfomycin (84%), and
Imipenem (84%) showing the greatest effectiveness. Moderate susceptibility was observed for Nitrofurantoin
(78%), Cefepime (73%), and Amikacin (73%), indicating their continued utility in selected cases. However,
resistance was notable against several commonly prescribed antibiotics. Lower sensitivity rates were seen with
Ceftazidime (62%), Norfloxacin (57%), Amoxicillin/Clavulanic acid (53%), and Tetracycline (52%). Results
are depicted in table :1.Alarmingly, very poor susceptibility was documented for Ciprofloxacin (30%),
Ampicillin (21%), underscoring the limited role of these agents in empirical therapy within this population.
Page 4033
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOVATION (IJRSI)
ISSN No. 2321-2705 | DOI: 10.51244/IJRSI |Volume XII Issue IX September 2025
Figure:1 Isolates obtained from Urine samples.
Table1: Antibiotic Susceptibility Pattern of E. coli Isolates (n = 94)
Category
Antibiotic
Susceptibility (%)
High Susceptibility (>80%)
Meropenem
91%
PiperacillinTazobactam
89%
Gentamicin
86%
Fosfomycin
84%
Imipenem
84%
Moderate Susceptibility (6080%)
Nitrofurantoin
78%
Cefepime
73%
Amikacin
73%
Ceftazidime
62%
Low Susceptibility (<60%)
Norfloxacin
57%
Amoxicillin/Clavulanic acid
53%
Tetracycline
52%
Ciprofloxacin
30%
Ampicillin
21%
DISCUSSION:
This departmental antibiogram highlights a clear stratification of antibiotic efficacy for Escherichia coli
urinary tract infections (UTIs) managed in the Medicine Department. Carbapenems such as meropenem (91%)
and imipenem (84%), along with β-lactam/β-lactamase inhibitor combinations like piperacillintazobactam
(89%), demonstrated high effectiveness (>85%), reaffirming their role as reserve drugs in complicated
infections.Among oral agents, fosfomycin (84%) and nitrofurantoin (78%) remain reliable first-line options for
outpatient management of uncomplicated UTIs. These results are consistent with Rizvi et.al, and Bhargava
et.al where nitrofurantoin susceptibility rates for E. coli ranged from 7892% , and fosfomycin maintained
>80% sensitivity, making them preferred oral empirical choices.
(11,12)
Conversely, fluoroquinolones showed
alarmingly high resistance, with ciprofloxacin demonstrating only 30% sensitivity and norfloxacin 57%,
paralleling ahirwar et .al and national Idata where fluoroquinolone resistance often exceeds 6070%.
(13,14)
Similarly, ampicillin was largely ineffective (21%), mirroring findings from kaur H et.al that report ampicillin
resistance >75% in community and hospital isolates.
(15)
Cephalosporins displayed moderate susceptibility, with
cefepime (73%) and ceftazidime (62%) showing limited reliability -a trend also reported from tertiary centres
in Delhi, Chandigarh, and Uttar Pradesh, where third-generation cephalosporin susceptibility for E. coli rarely
exceeds 6570% due to high ESBL prevalence.
(12,13)
These findings emphasize the need for susceptibility-
guided use of cephalosporins to prevent treatment failures. Overall, these results mirror broader Indian AMR
surveillance trends, including those reported in the ICMR-AMRSN network, which consistently highlight
escalating fluoroquinolone and aminopenicillin resistance in E. coli, stable nitrofurantoin efficacy, and high
retained activity of carbapenems.
(14,16)
Our findings therefore reinforce the necessity of: Regular, department-
wise antibiogram updates (at least annually)
,Integration with hospital antimicrobial stewardship programs
(AMSPs)
,Judicious carbapenem use to preserve their activity for multidrug-resistant infections
.Such efforts
Page 4034
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOVATION (IJRSI)
ISSN No. 2321-2705 | DOI: 10.51244/IJRSI |Volume XII Issue IX September 2025
are crucial to optimizing empirical therapy, improving clinical outcomes, and curbing the acceleration of
antimicrobial resistance in the region.
CONCLUSION:
The Medicine Department contributed the largest sample load in 2024, with E. coli emerging as the
predominant isolate. The organism retained high susceptibility to carbapenems, piperacillintazobactam, and
fosfomycin, but showed poor response to fluoroquinolones and ampicillin. Department-specific antibiograms
thus remain invaluable for guiding empirical therapy and should be routinely disseminated to treating
physicians to optimize antibiotic selection. For uncomplicated UTIs, oral agents such as fosfomycin and
nitrofurantoin should be prioritized, while carbapenems must be preserved for resistant or severe infections to
prevent the acceleration of antimicrobial resistance.
REFERENCES
1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology,
mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):26984.
2. Gupta K, Trautner BW. Urinary tract infections, pyelonephritis, and prostatitis. In: Bennett JE,
Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious
Diseases. 9th ed. Elsevier; 2020. p. 886913.
3. Nazir A, Kanth F. Bacteriological profile and antimicrobial susceptibility pattern of patients with
urinary tract infections in a tertiary care hospital in a tertiary care center. Journal of Research in
Applied and Basic Medical Sciences 2024; 10 (2) :110-120
4. Sánchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary
Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents
Chemotherapy. 2012;56(4):21813.
5. Gandra S, Joshi J, Trett A, Lamkang AS, Laxminarayan R. Scoping report on antimicrobial
resistance in India. Washington, DC: Center for Disease Dynamics, Economics & Policy; 2017.
6. J G Collee, A G Fraser, B P Marimon, A Simmons. . Laboratory strategy in the diagnosis of infective
syndrome: Urinary tract infection. Mackey& McCartney practical medical microbiology 1999.
7. M Cheesebrough. Examination of Urine. District laboratory practicein tropical countries. Part
II 2000
8. B A Forbes, D F Sahm, A S Weissfeld. . Infection of urinary tract. Bailey and scotts diagnostic
microbiology 2002.
9. S G Gatterman, S P Borriello, P R Murray, G Funke. Bacterial infection of urinary tract. Topley and
wilsonsmicrobiology and microbial infections, Bacteriology 2005.
10. Clinical Laboratory Standards Institute (CLSI) guidelines. Performance standards for antimicrobial
susceptibility testing: Thirty fourth informational supplement. CLSI document M100-S34. Clinical
and Laboratory Standards Institute. Pennsylvania; Wayne; 2024.
11. Rizvi M, Sultan A, Khan F, et al. Regional variations in antimicrobial susceptibility of Escherichia
coli from community-acquired urinary tract infections across India: Results from the ICARE
surveillance network. Indian J Med Microbiol. 2024;42(1):25-33. doi:10.1016/j.ijmmb.2023.10.005
12. Bhargava A, Sharma S, Negi V, et al. Bacteriological profile and antimicrobial resistance pattern of
urinary tract infections in a tertiary care hospital from Northern India. Front Microbiol.
2022;13:965053. doi:10.3389/fmicb.2022.965053
13. Ahirwar N, et al. Prevalence and antimicrobial resistance patterns of uropathogens in suspected
urinary tract infection cases: A retrospective observational study from North India. Med Sci Forum.
2023;24(1):16. doi:10.3390/msf2023024016
14. ICMR-AMRSN Annual Report 2023: Antimicrobial resistance trends among priority pathogens in
India. Indian Council of Medical Research; 202
Page 4035
www.rsisinternational.org
INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOVATION (IJRSI)
ISSN No. 2321-2705 | DOI: 10.51244/IJRSI |Volume XII Issue IX September 2025
15. Kaur H, et al. Antimicrobial susceptibility profile of uropathogens in rural Himachal Pradesh, India:
Are we heading towards resistance? J Family Med Prim Care. 2019;8(9):28932899.
doi:10.4103/jfmpc.jfmpc_455_19
16. Gandra S, et al. Trends in antibiotic resistance among major bacterial pathogens in India: Results
from the ICMR antimicrobial resistance surveillance network. Lancet Infect Dis. 2023;23(1):33-45.
doi:10.1016/S1473-3099(22)00407-4